Orixha

Description

Orixha develops a proprietary Total Liquid Ventilation clinical platform, LuncoLive, that circulates a breathable liquid to ventilate lungs and provide respiratory support for intubated, comatose, and critical care patients.

Related

• EEbenbuildEbenbuild develops lung digital twin technology that combines physics-based modeling with patient data to create virtual lung replicas for…
• AerogenAerogen designs and supplies vibrating mesh nebuliser systems and accessories that facilitate aerosol drug delivery for invasive mechanical…
• AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…
• TendertecTendertec builds privacy-first technology-enabled care infrastructure and AI-powered sensing products (Hestia) for homes, hospitals and…
• KiroKiro builds clinical AI that connects to laboratories and healthcare systems to decode biological data into clinically grounded insights…
• GlycanosticsGlycanostics develops non-invasive liquid biopsy cancer diagnostics, building antibody-coated magnetic particle tests that detect glycan…
• XENOTHERAXENOTHERA develops glyco humanized antibody technology for immunological treatments, lists pipeline products and clinical trials for…
• Hedera DxHedera Dx enables hospital laboratories to perform in-house NGS genomic profiling, offering FFPE, ctDNA (liquid biopsy) and RNA-only…
• CyclomicsCyclomics develops molecular diagnostics and DNA sequencing products including the CySeq consensus sequencing and liquid biopsy platform…